BioSig Announces Proposed Public Offering of Common Stock
23 juin 2022 16h26 HE
|
BioSig Technologies, Inc.
Westport, CT, June 23, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal...
BioSig Announces New Evaluation Agreement for its PURE EP System with Cleveland Clinic
22 juin 2022 08h00 HE
|
BioSig Technologies, Inc.
Westport, CT, June 22, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company advancing electrophysiology workflow by delivering...
Organ Care System Market for Heart Expected to Accumulate a Revenue of $37.2 Million by 2026, Growing at a Healthy CAGR of 16.5% | Reveals [90-Pages] by Research Dive
08 juin 2022 09h00 HE
|
Research Dive
New York, USA, June 08, 2022 (GLOBE NEWSWIRE) -- According to the latest report published by Research Dive, the global organ care system market for heart is anticipated to rise at a stable CAGR of...
BioSig Advances its PURE™ System Commercial Launch to Medical Centers Nationwide
26 mai 2022 09h08 HE
|
BioSig Technologies, Inc.
Westport, CT, May 26, 2022 (GLOBE NEWSWIRE) -- Commercial pipeline to include 30 advanced leads at Medical Centers of Excellence Company’s development and operational infrastructure...
BioSig’s PURE EP™ System to be Featured During EPLive 2022
25 mai 2022 09h47 HE
|
BioSig Technologies, Inc.
Westport, CT, May 25, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company advancing electrophysiology workflow by delivering...
BioSig Technologies, Inc. Issues Shareholder Letter with Corporate Update on Recent Achievements
11 mai 2022 08h30 HE
|
BioSig Technologies, Inc.
Westport, CT, May 11, 2022 (GLOBE NEWSWIRE) -- To date, Company's FDA 510(k) cleared PURE EP(TM) system has completed over 2,200 patient cases with 75 physicians at 17 hospitals across the...
BioSig to Present at Heart Rhythm 2022
19 avr. 2022 09h10 HE
|
BioSig Technologies, Inc.
Westport, CT, April 19, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company advancing electrophysiology workflow by delivering...
BioSig to Present at NobleCon18 Capital Markets Conference
07 avr. 2022 08h30 HE
|
BioSig Technologies, Inc.
Westport, CT, April 07, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing...
BioSig Technologies, Inc. Partners with Summit Blue Capital to Provide Equipment Leasing Services
29 mars 2022 10h06 HE
|
BioSig Technologies, Inc.
Westport, CT, March 29, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
BioSig Announces Closing of Public Offering of Common Stock
23 mars 2022 08h00 HE
|
BioSig Technologies, Inc.
Westport, CT, March 23, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal...